It’s been a mixed two weeks for small-cap health companies, with only 40 companies gaining ground, 72 losing it and 24 flatlining.

 

Here’s a table showing how ASX-listed healthcare stocks have been performing.

Code Company Price % Six Month % Month % Week Market Cap
IBX Imagion Biosys Ltd 0.089 11 20 27 $ 106,310,445.70
NC6 Nanollose Limited 0.1325 47 58 26 $ 20,072,659.68
IVX Invion Ltd 0.029 190 123 26 $ 158,349,845.24
MEM Memphasys Ltd 0.075 21 19 25 $ 61,789,910.29
MDC Medlab Clinical Ltd 0.185 0 19 19 $ 63,302,499.14
PAR Paradigm Bio. 2.4 7 28 17 $ 547,622,200.89
CPH Creso Pharma Ltd 0.15 -21 30 15 $ 174,946,768.37
IMU Imugene Limited 0.5975 130 34 15 $ 3,426,180,200.85
ACW Actinogen Medical 0.165 189 50 14 $ 275,955,660.26
IHL Incannex Healthcare 0.525 72 54 13 $ 670,733,041.67
UBI Universal Biosensors 0.8 14 5 10 $ 136,850,315.14
GTG Genetic Technologies 0.0065 -19 -7 8 $ 55,403,790.86
ADR Adherium Ltd 0.013 -24 -19 8 $ 27,667,219.48
PAA Pharmaust Limited 0.105 9 17 8 $ 33,275,800.22
PYC PYC Therapeutics 0.15 -9 3 7 $ 477,138,915.45
RHY Rhythm Biosciences 1.82 104 52 7 $ 402,984,156.33
MDR Medadvisor Limited 0.395 32 25 7 $ 149,102,779.84
PXS Pharmaxis Ltd 0.1225 44 -2 7 $ 56,800,076.75
ZLD Zelira Therapeutics 0.04 -26 3 5 $ 52,325,497.32
EXL Elixinol Wellness 0.0955 -38 -4 5 $ 30,959,295.25
PIQ Proteomics Int Lab 0.985 -2 12 5 $ 105,127,595.63
KZA Kazia Therapeutics 1.55 14 7 4 $ 208,769,729.18
MXC Mgc Pharmaceuticals 0.048 -21 -17 2 $ 117,800,696.90
ACR Acrux Limited 0.125 -17 -4 4 $ 35,460,042.25
AGH Althea Group 0.275 -33 6 4 $ 79,748,610.50
TD1 Tali Digital Limited 0.029 -29 0 4 $ 27,025,267.88
CAN Cann Group Ltd 0.3 -39 3 3 $ 104,656,350.90
PAB Patrys Limited 0.038 66 -11 3 $ 74,269,178.84
IMM Immutep Ltd 0.605 42 13 3 $ 597,710,960.70
M7T Mach7 Tech Limited 0.925 -19 -5 2 $ 208,811,724.00
PSQ Pacific Smiles Grp 2.96 6 12 2 $ 470,766,717.10
S66 Star Combo 0.275 10 -4 2 $ 37,045,928.98
BOT Botanix Pharma Ltd 0.061 -25 -9 2 $ 60,334,808.59
GLH Global Health Ltd 0.365 -34 -4 1 $ 20,096,334.16
TRU Truscreen 0.078 -3 37 1 $ 29,029,300.24
EZZ EZZ Life Science 0.49 -19 -8 1 $ 5,760,000.00
ARX Aroa Biosurgery 1.135 -1 -5 1 $ 382,886,353.92
ALC Alcidion Group Ltd 0.3625 -2 2 1 $ 387,785,549.24
CYC Cyclopharm Limited 1.85 -34 12 1 $ 171,809,674.32
MVF Monash IVF Group Ltd 0.945 7 1 1 $ 375,997,620.60
ONT 1300 Smiles Limited 8.09 10 0 0 $ 192,268,478.08
VBS Vectus Biosystems 1.65 72 10 0 $ 52,586,329.95
SDI SDI Limited 1.02 20 3 0 $ 120,648,512.95
SCU Stemcell United Ltd 0.014 -22 0 0 $ 14,606,489.21
OVN Oventus Medical Ltd 0.105 -36 -22 0 $ 24,172,653.50
OSL Oncosil Medical 0.049 -46 4 0 $ 39,617,164.70
IRX Inhalerx Limited 0.1 -5 0 0 $ 16,172,827.87
JTL Jayex Technology Ltd 0.023 -39 5 0 $ 5,732,256.40
JHC Japara Healthcare Lt 1.4 42 1 0 $ 379,509,698.40
IMC Immuron Limited 0.13 -26 -16 0 $ 28,447,449.50
ICS ICSGlobal Limited 0.575313 4 0 0 $ 6,054,604.94
HXL Hexima 0.37 111 -3 0 $ 53,106,783.02
GSS Genetic Signatures 1.375 9 -5 0 $ 195,959,657.02
FFC Farmaforce Ltd 0.051 -36 0 0 $ 6,664,729.98
CTE Cryosite Limited 0.34 3 -8 0 $ 16,595,251.42
CHM Chimeric Therapeutic 0.305 22 5 0 $ 66,556,231.36
CDY Cellmid Limited 0.065 -3 2 0 $ 14,314,133.93
BNO Bionomics Limited 0.125 -48 -7 0 $ 131,247,576.72
AVE Avecho Biotech Ltd 0.017 -6 -8 0 $ 31,213,980.94
ATH Alterity Therap Ltd 0.028 -3 -10 0 $ 69,799,362.76
ALT Analytica Limited 0.002 -33 0 0 $ 9,227,602.26
AHK Ark Mines Limited 0.034 0 0 0 $ 1,778,919.95
VLS Vita Life Sciences.. 1.895 90 20 0 $ 100,566,488.92
4DX 4Dmedical Limited 1.335 -6 -1 0 $ 284,179,837.68
NXS Next Science Limited 1.28 -28 2 -1 $ 253,406,603.52
OPT Opthea Limited 1.25 -10 -4 -1 $ 446,010,385.60
CU6 Clarity Pharma 1.05 -7 -1 $ 170,415,128.43
BDX Bcaldiagnostics 0.1525 -2 -2 $ 19,728,984.30
MX1 Micro-X Limited 0.305 -5 -2 -2 $ 142,639,600.95
PGC Paragon Care Limited 0.3 43 -5 -2 $ 108,934,216.69
MVP Medical Developments 4.95 -11 -4 -2 $ 359,173,946.88
OSX Osteopore Limited 0.24 -52 -14 -2 $ 28,144,377.12
SHG Singular Health 0.235 -28 21 -2 $ 15,526,435.68
PCK Painchek Ltd 0.047 -28 2 -2 $ 52,063,020.75
ANP Antisense Therapeut. 0.225 29 7 -2 $ 134,850,983.38
OIL Optiscan Imaging 0.2 -49 -13 -2 $ 136,000,832.44
EYE Nova EYE Medical Ltd 0.4 18 -1 -2 $ 61,132,592.22
BWX BWX Limited 4.57 -2 -5 -3 $ 743,303,128.26
PBP Probiotec Limited 2.12 5 -6 -3 $ 165,557,786.66
IPD Impedimed Limited 0.175 46 35 -3 $ 302,156,736.88
NSB Neuroscientific 0.345 35 -17 -3 $ 48,780,358.62
CAJ Capitol Health 0.33 -8 -11 -3 $ 326,339,216.28
AC8 Auscann Grp Hlgs Ltd 0.097 -22 8 -3 $ 44,054,711.00
NTI Neurotech Intl 0.063 7 19 -3 $ 45,293,243.19
CBL Control Bionics 0.465 -33 -23 -3 $ 24,662,143.94
ILA Island Pharma 0.3 -23 -9 -3 $ 13,097,665.63
1AD Adalta Limited 0.085 -37 -2 -3 $ 20,595,084.55
AHC Austco Healthcare 0.14 43 0 -3 $ 39,786,453.14
CGS Cogstate Ltd 2.23 131 -7 -4 $ 390,079,760.64
BIT Biotron Limited 0.049 -9 -6 -4 $ 35,096,635.65
DXB Dimerix Ltd 0.24 -6 -17 -4 $ 77,009,679.84
VTI Vision Tech Inc 0.95 -32 -5 -4 $ 23,517,322.50
RAC Race Oncology Ltd 3.23 -1 1 -4 $ 487,994,124.06
PAL Palla Pharma Ltd 0.345 -22 5 -4 $ 55,050,475.42
DVL Dorsavi Ltd 0.023 -23 28 -4 $ 8,082,949.16
SOM SomnoMed Limited 2.42 13 3 -4 $ 200,277,542.30
BD1 Bard1 Life Sciences 0.975 -62 -11 -4 $ 90,555,896.20
ZNO Zoono Group Ltd 0.42 -38 1 -5 $ 72,737,591.08
ADO Anteotech Ltd 0.205 -36 -11 -5 $ 394,378,343.20
AMT Allegra Orthopaedics 0.2 -33 -13 -5 $ 20,891,840.60
LBT LBT Innovations 0.095 22 -14 -5 $ 28,911,516.40
LDX Lumos Diagnostics 0.81 -13 -5 $ 120,341,592.00
HCT Holista CollTech Ltd 0.054 8 -10 -5 $ 14,868,850.70
RGS Regeneus Ltd 0.069 -31 -8 -5 $ 22,369,894.72
TLX Telix Pharmaceutical 6.78 72 21 -6 $ 2,015,465,459.56
ONE Oneview Healthcare 0.335 12 -20 -6 $ 140,876,207.23
MMJ MMJ Group Hlds Ltd 0.066 -34 -10 -6 $ 15,406,917.00
IDT IDT Australia Ltd 0.47 42 -25 -6 $ 107,937,076.50
CDX Cardiex Limited 0.062 -7 -15 -6 $ 59,959,323.21
OCC Orthocell Limited 0.5 -6 -2 -7 $ 96,041,559.00
ALA Arovella Therapeutic 0.039 3 -15 -7 $ 21,156,079.38
ATX Amplia Therapeutics 0.18 -29 -12 -8 $ 23,091,947.90
RCE Recce Pharmaceutical 0.89 -23 -4 -8 $ 159,884,819.24
OSP Osprey Med Inc 0.83 -51 4 -8 $ 21,681,467.99
CMP Compumedics Limited 0.355 -16 -10 -8 $ 62,892,846.54
NYR Nyrada Inc. 0.235 -23 0 -8 $ 29,496,683.28
DOC Doctor Care Anywhere 0.615 -37 -13 -8 $ 116,976,958.76
CYP Cynata Therapeutics 0.55 -7 -11 -8 $ 80,951,275.61
NEU Neuren Pharmaceut. 1.69 37 -16 -9 $ 215,401,305.96
ICR Intelicare Holdings 0.105 -60 0 -9 $ 5,050,566.26
AT1 Atomo Diagnostics 0.255 24 -28 -9 $ 102,172,584.25
RHT Resonance Health 0.1 -47 15 -9 $ 48,389,458.01
VHT Volpara Health Tech 1.13 -13 -8 -10 $ 292,826,339.37
RSH Respiri Limited 0.055 -48 -15 -10 $ 39,756,243.45
EPN Epsilon Healthcare 0.1125 -38 2 -10 $ 22,161,299.14
NOX Noxopharm Limited 0.46 -20 -22 -12 $ 137,351,836.50
1ST 1St Group Ltd 0.015 -23 -17 -12 $ 8,060,414.83
PTX Prescient Ltd 0.25 181 4 -12 $ 164,379,303.09
MEB Medibio Limited 0.007 0 -36 -13 $ 12,565,430.49
RNO Rhinomed Ltd 0.25 56 -19 -14 $ 68,528,465.64
PNV Polynovo Limited 1.555 -44 -11 -17 $ 1,051,606,989.96
RAP Resapp Health Ltd 0.05 4 -26 -18 $ 42,100,656.77
BPH BPH Energy Ltd 0.047 -42 -20 -19 $ 29,921,372.51
BXN Bioxyne Ltd 0.024 0 9 -20 $ 15,363,489.55
TSN The Sust Nutri Grp 0.2 -62 -32 -20 $ 20,392,340.85
LCT Living Cell Tech. 0.007 -42 -36 -22 $ 5,710,809.81

 

Imagion Biosystems (ASX:IBX) was the biggest winner up 27% off the back of its Q3 2021 report which noted that patient screening and overall HER2 patient numbers were below pre-pandemic levels.

The company was flagged with a speeding ticket after a change in the price from a low of $0.077 at close of trading on 8 November 2021 and a high of $0.102 on 9 November 2021 – and a significant increase in the volume of IBX securities traded on 9 November 2021.

Imagion said it didn’t know why, and that it had noted in its quarterly that multiple patients had been enrolled in the study and that four sites are now actively screening patients.

However, if patient accessibility continued to be slow, the target of completing enrolment into its MagSense HER2 breast cancer Phase I first-in-human study by the end of 2021 would be difficult.

Next up was Nanollose (ASX:NC6) up 26% on no news, followed by Invion (ASX:IVX) also up 20% after reporting pre-clinical studies had shown “complete regression of triple negative breast cancer (TNBC) in vivo (on mice)” following application of its INV043 treatment.

This also sets the stage for the company to progress INV043 towards clinical trials.

Then there was Memphasys (ASX:MEM), which jumped 25% off the back of completing verification and validation assessments for its Felix sperm separation device for early access markets with low regulatory requirements.

“We continue to believe that a maiden commercial sale can be made prior to the end of the calendar year,” Memphasys executive chairman Alison Coutts said.

 

Who flatlined?

Immuron (ASX:IMC) was flat despite the US Naval Medical Research Centre (NMRC) reporting that most of the inpatient clinical trial sites in the USA are coming off COVID-19 based restrictions.

The company is planning an IND submission to the US FDA for Q1 CY2022 to support two human Phase II clinical trials.

Cellmid (ASX:CDY) was also flat even after acquiring BLC Cosmetics Pty Ltd for $1 million – which it says is a profitable business with revenue around $7 million and growing.

 

Who’s the biggest loser?

The biggest loser was Living Cell Technologies (ASX:LCT) which dropped 22% despite receiving a NZ$394,239.87 New Zealand R&D tax credit which it says it will put towards its third clinical trial of NTCELL for Parkinson’s disease.

Next up was The Sustainable Nutrition Group (ASX:TSN), down 20% off the back of its September quarterly which detailed revenue of $820,413 – 47% higher than the previous quarter and 248% higher than Q1 FY21.

The company said this was a result of the first full quarter of sales from initial supply agreements with Woolworths, and Coles.

And also down 20% was Bioxyne (ASX:BXN) after coming out of a trading halt and announcing it would not be proceeding with a proposed acquisition.